Recording intelligenceAI-generated brief · check the source for context

This Week in Virology Episode 1309

1:46:24 recording · AUTO · 4 speakers

Listen to the original

Listen to the episode
Executive Summary AI
  • Vincent Racaniello takes up a paper in NPJ Vaccines, "Post-Attachment Neutralization of HPV-16 by Antibodies Derived from Gardasil Vaccinated Women", first author Patricia Day and senior author John Schiller, from the National Cancer Institute at NIH with Emory and the Fred Hutchinson Cancer Center, because listeners kept asking why the HPV vaccine is called sterilizing.10:12
  • The panel explains that HPV has to reach the basal keratinocytes through a break in the mucosa, attach to heparin sulfate proteoglycans on the basement membrane, expose L2, be cleaved by furin and change conformation again before entry — a process that takes hours and leaves a long window for antibodies.18:11
  • Using HACAT keratinocytes, sera from Gardasil-vaccinated women and 13 monoclonals from memory B cells, the team still saw inhibition of infectivity 18 hours after attachment, by three mechanisms — retention at the cell surface, antibody-induced shedding, and degradation inside the cell that is not TRIM21-mediated — and the same mechanisms showed up in polyclonal serum.23:54
  • The second paper, published in Cell, "Respiratory viral infections prime accelerated lung cancer growth", has co-first authors Wei Qian and Zhao-Qin Wei and senior author Ji Sun, with teams from the University of Virginia, the University of Pittsburgh, the Mayo Clinic in Jacksonville and Cedars-Sinai.43:40
  • In Epic Cosmos records starting from 75.9 million adults, prior severe COVID-19 carried a 1.24-fold higher lung cancer hazard, and mouse work traced it to Siglec-F-high lung-resident neutrophils driven by G-CSF and TGF-beta — with vaccination, neutrophil blockade and anti-PD-L1 all reducing tumor burden.52:55

Brief overview

Two papers: HPV vaccines uniquely block infection, while severe viral pneumonia primes neutrophils that accelerate lung cancer.

  1. HPV vaccine may be the only one preventing infectionVincent says that after reading the literature he concluded it is the only vaccine that prevents infection, not just disease.
  2. Slow HPV entry gives antibodies an unusual windowBinding, furin cleavage and conformational changes take hours, so neutralization still works 18 hours after the virus has attached.
  3. Severe viral pneumonia leaves a pro-tumor lungPrior severe COVID or influenza reprograms lung-resident neutrophils to Siglec-F-high, and vaccination prevents that in mice.

Questions this recording answers

10 questions, each answered where it is said
Do vaccines usually prevent infection, or only disease?

The literature says vaccines prevent disease but permit infection, because the memory response is a few days delayed, so the virus gets in and replicates. Very high antibody or T-cell levels shortly after vaccination might block infection, but not over the long term. HPV is the exception.

Answered around 11:30
How well did the HPV vaccine prevent infection in the Costa Rica trial?

In the 2011 Guanacaste, Costa Rica community-based randomized trial, infection measured by PCR because the virus is hard to grow, efficacy against HPV 16 and 18 was 90 percent, less than the claim it was cited for, but at year four it reached 100 percent, getting better with time.

Answered around 17:07
How does human papillomavirus reach the cells it infects?

In the cervix the mucosal epithelium is layered, and the virus must reach the basal keratinocytes, which it cannot do without a break in the mucosa. It binds heparin sulfate proteoglycans on the basement membrane, which exposes the minor capsid protein L2; furin cleaves it, and further changes let L1 bind its receptor.

Answered around 18:11
Why do antibodies have such a long window to stop this virus?

Because entry takes hours rather than minutes. Antibodies added three hours after the virus had attached still neutralized, and at eighteen hours post-attachment there was still some inhibition of infectivity, unusual since most viruses bind and are taken in quickly by endocytosis. That slow, multi-step entry is the opening.

Answered around 19:19
How do antibodies neutralize the virus after it has already attached?

One mechanism is that the antibody pushes the particle off the cell surface, inducing shedding. Another brings it inside the cell where it is degraded, though not through TRIM21, which is not involved here. A third simply retains the particle on the surface. Different antibodies use these in different combinations.

Answered around 30:45
How long do the plasma cells that make antibody live?

Years. There are long-lived and short-lived plasma cell subtypes in different anatomic locations. Once a cell has differentiated all the way to a plasma cell it cannot divide again or become anything else; it just produces antibody. But some memory cells can differentiate into plasma cells.

Answered around 35:18
Does severe COVID raise the risk of a later lung cancer diagnosis?

In the Epic Cosmos medical records, severe COVID requiring hospitalization was associated with a 1.24-fold higher lung cancer hazard after adjustment for comorbidities, and those patients had the highest cumulative hazard. Prior non-severe infection was instead associated with a moderate decrease in lung cancer diagnoses.

Answered around 52:30
Did vaccinating the mice prevent the accelerated tumor growth?

Yes. Two doses of spike-encoding mRNA vaccine substantially reduced tumor burden compared with mock-immunized mice, and an inactivated influenza vaccine did the same. The vaccine appears to work by preventing severe disease: a low dose causing only moderate disease did not increase tumor burden.

Answered around 56:49
Which cells make the lung a good place for a tumor after infection?

Neutrophils. Clustering showed clusters 1, 5 and 6 highly enriched for Siglec-F, a marker of pro-tumor neutrophils, which sit in the lung parenchyma. Implanting tumor cells together with Siglec-F-high neutrophils gave a bigger tumor mass than Siglec-F-low ones, and vaccinated mice lacked them.

Answered around 1:02:14
Could anything reverse that pro-tumor lung environment in the mice?

Partly. An antibody to Ly6G plus reparixin, which blocks chemokine receptor 2 signaling, given before tumor inoculation, reduced lung neutrophils, decreased tumor burden and improved survival, though not completely. Adding anti-PD-L1 to the neutrophil blockade significantly suppressed tumor burden in infected tumor-bearing mice.

Answered around 1:15:01
Key Quote

“it is, it is the only vaccine that prevents infection.”

— Vincent Racaniello, This Week in Virology Episode 1309, at 12:02▶ listen at 12:02
Key Quote

“So this is, I think we've mentioned this before, This is vaccinologists fooling Mother Nature.”

— Rich Condit, This Week in Virology Episode 1309, at 41:19▶ listen at 41:19
Key Quote

“So neutrophils are innate immune cells that basically largely work by phagocytosis.”

— Breanne Barker, This Week in Virology Episode 1309, at 49:06▶ listen at 49:06
Key Quote

“Well, look, folks, if you don't want to get lung cancer after respiratory virus infection, just get a vaccine.”

— Vincent Racaniello, This Week in Virology Episode 1309, at 1:21:28▶ listen at 1:21:28

Cite this

“This Week in Virology Episode 1309.” https://traffic.libsyn.com/secure/twiv/TWiV1309.mp3. Transcript summary by WhipScribe, https://whipscribe.com/transcript-pages/this-week-in-virology-episode-1309.html.

Report this page
What is wrong with this page?